69 results
8-K
EX-99.1
TVTX
Travere Therapeutics Inc
13 May 24
Departure of Directors or Certain Officers
4:05pm
of the Company’s products (including with group purchasing organizations, distributors and other vendors); (58) supply chain achievements (including
8-K
EX-99.1
TVTX
Travere Therapeutics Inc
6 May 24
Travere Therapeutics Reports First Quarter 2024 Financial Results
4:05pm
, commercialization activity, supply chain, and manufacturing operations. You are cautioned not to place undue reliance on these forward-looking statements
8-K
TVTX
Travere Therapeutics Inc
24 Apr 24
Other Events
4:05pm
health epidemics and pandemics, including risks related to potential disruptions to clinical trials, commercialization activity, supply chain
8-K
php776 7e6l0cqzv5
23 Feb 24
Other Events
4:05pm
8-K
EX-99.1
hnd2a8f w2u5ea7bld
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
EX-99.1
1p5d4y6n3orjsf y9fv
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
bblnp vn0q77jdgybgzf
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
EX-99.1
euotthb
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
kw0d9u5i0a6
21 Sep 23
Other Events
7:35am
8-K
EX-99.1
fd1j7lt
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
xa6xsd31 ow
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
945n4u
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
erqm32jl
1 May 23
Other Events
4:07pm